Department of Process Research and Development , Merck & Co., Inc. , Rahway , New Jersey 07065 , United States.
J Am Chem Soc. 2019 Jan 30;141(4):1441-1445. doi: 10.1021/jacs.8b11800. Epub 2019 Jan 18.
Herein we describe the development and application of a method for the mild, late-stage conversion of primary sulfonamides to several other other functional groups. These reactions occur via initial reductive deamination of sulfonamides to sulfinates via an NHC-catalyzed reaction of transiently formed N-sulfonylimines. The method described here is tolerant of nearly all common functional groups, as exemplified by the late-stage derivatization of several complex pharmaceutical compounds. On the basis of the prevalence of sulfonamide-containing drugs and building blocks, we have developed a method to enable sulfonamides to be applied as versatile synthetic handles for synthetic chemsitry.
在此,我们描述了一种温和的、晚期转化的主要磺胺类药物到其他几种功能基团的方法的开发和应用。这些反应通过 NHC 催化的瞬态 N-磺酰亚胺的反应,最初将磺胺类药物还原脱氨为亚磺酸盐来发生。这里描述的方法对几乎所有常见的官能团都具有耐受性,这可以通过对几个复杂药物化合物的晚期衍生化来证明。基于含磺胺药物和构建块的普遍性,我们已经开发了一种方法,使磺胺类药物能够作为合成化学的通用合成处理剂。